Lisa A Conte Jaguar Health, Inc. (JAGX) insider trading activity

Lisa A Conte is CEO and President of Jaguar Health, Inc.. Currently has a direct ownership of 666 shares of JAGX, which is worth approximately $2,937. The most recent transaction as insider was on May 17, 2025, when has been sold 2 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 666

95.99% 3M change

90.87% 12M change

Total Value Held $2,937

LISA A CONTE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 17 2025	BUY Exercise of conversion of derivative security	-	2 Added 0.3%	666 Common Stock
Oct 08 2024	BUY Grant, award, or other acquisition	-	16,503 Added 49.82%	16,624 Common Stock
May 17 2024	BUY Exercise of conversion of derivative security	-	2,695 Added 26.98%	7,295 Common Stock
Apr 05 2024	BUY Exercise of conversion of derivative security	-	600 Added 11.54%	4,600 Common Stock
Aug 14 2023	BUY Grant, award, or other acquisition	-	383,605 Added 49.74%	387,605 Common Stock
May 17 2023	BUY Exercise of conversion of derivative security	-	2,694 Added 40.24%	4,000 Common Stock
Apr 05 2023	BUY Exercise of conversion of derivative security	-	600 Added 31.48%	1,306 Common Stock
Apr 05 2022	BUY Exercise of conversion of derivative security	-	45,000 Added 45.92%	53,003 Common Stock
Sep 13 2021	BUY Open market or private purchase	$20,000 $2.51 p/Share	7,968 Added 49.89%	8,003 Common Stock

LAC

Lisa A Conte

CEO and President

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAGX shares.

Notify only if

Value

Insider Trading

Get notified when an Jaguar Health, Inc. insider buys or sells JAGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jaguar Health, Inc.

Track Activities on JAGX

Account